ReviewEuropean journal of clinical pharmacology2011

Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

Francesco Bellanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.